SCHEMBL13726561

SCHEMBL13726561

FC(F)(F)c1ccc(C2NCc3c(Cl)cccc3-n3cccc32)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.45
▸ MEN1 O00255 9/20 0.45
▸ ATM Q13315 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ HSD17B10 Q99714 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ SIRT6 Q8N6T7 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15465626 0.99 KMT2A (0.47) KMT2AMEN1ATML3MBTL1HSD17B10
SCHEMBL13726674 0.88 KMT2A (0.48) KMT2AMEN1ATML3MBTL1HSD17B10
SCHEMBL13726995 0.88 KMT2A (0.41) KMT2AMEN1ATML3MBTL1HSD17B10
Hydrochloric Acid SCHEMBL15466041 0.88 KMT2A (0.50) KMT2AMEN1ATML3MBTL1HSD17B10
SCHEMBL13727098 0.88 KMT2A (0.45) KMT2AMEN1ATML3MBTL1HSD17B10
SCHEMBL13728225 0.87 KMT2A (0.47) KMT2AMEN1ATML3MBTL1HSD17B10
Hydrochloric Acid SCHEMBL15466249 0.87 KMT2A (0.47) KMT2AMEN1ATML3MBTL1HSD17B10
Hydrochloric Acid SCHEMBL15465050 0.86 KMT2A (0.48) KMT2AMEN1ATML3MBTL1HSD17B10
SCHEMBL13728460 0.85 MEN1 (0.42) KMT2AMEN1ATML3MBTL1HSD17B10
Hydrochloric Acid SCHEMBL15464669 0.84 MEN1 (0.43) KMT2AMEN1ATML3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106674226-B Antifungal compounds substituted with heterocyclic derivatives 詹森药业有限公司 2020-05-26 — — CN disclosed
US-9975899-B2 Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives JANSSEN PHARMACEUTICA NV (BE) 2018-05-22 — — US disclosed
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2017-03-16 — — US disclosed
EP-2707370-B1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2015-04-29 — — EP disclosed
EP-2707370-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES Janssen Pharmaceutica, N.V. (BE) 2014-03-19 — — EP disclosed
WO-2012150305-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO- DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2012-11-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170073348-A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES GABBR1, HRH4, CYP1B1 KMT2A 1516/4885MEN1 2589/4885ATM 4777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback